JP5519879B2 - ミルラの新規な適用としての更年期症状としての膣の委縮の処置 - Google Patents
ミルラの新規な適用としての更年期症状としての膣の委縮の処置 Download PDFInfo
- Publication number
- JP5519879B2 JP5519879B2 JP2013555906A JP2013555906A JP5519879B2 JP 5519879 B2 JP5519879 B2 JP 5519879B2 JP 2013555906 A JP2013555906 A JP 2013555906A JP 2013555906 A JP2013555906 A JP 2013555906A JP 5519879 B2 JP5519879 B2 JP 5519879B2
- Authority
- JP
- Japan
- Prior art keywords
- vaginal
- myrrh
- atrophy
- agent
- specifically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000007311 Commiphora myrrha Species 0.000 title claims description 75
- 235000006965 Commiphora myrrha Nutrition 0.000 title claims description 75
- 235000007265 Myrrhis odorata Nutrition 0.000 title claims description 67
- 206010003694 Atrophy Diseases 0.000 title claims description 33
- 230000037444 atrophy Effects 0.000 title claims description 33
- 206010027304 Menopausal symptoms Diseases 0.000 title claims description 25
- 239000000203 mixture Substances 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 21
- 239000002775 capsule Substances 0.000 claims description 19
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 19
- 239000002552 dosage form Substances 0.000 claims description 15
- 239000000829 suppository Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 235000019868 cocoa butter Nutrition 0.000 claims description 10
- 229940110456 cocoa butter Drugs 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 9
- 239000006216 vaginal suppository Substances 0.000 claims description 9
- 239000000003 vaginal tablet Substances 0.000 claims description 9
- 229940081859 myrrh extract Drugs 0.000 claims description 8
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 229940120293 vaginal suppository Drugs 0.000 claims description 7
- 229940044977 vaginal tablet Drugs 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 6
- 235000019197 fats Nutrition 0.000 claims description 6
- 229940098465 tincture Drugs 0.000 claims description 6
- 229940116364 hard fat Drugs 0.000 claims description 5
- 239000000155 melt Substances 0.000 claims description 5
- BZQURGSQMBBPRU-DZGCQCFKSA-N (4as,8as)-3,8a-dimethyl-5-methylidene-4,4a,6,9-tetrahydrobenzo[f][1]benzofuran Chemical compound C([C@]1(C)C2)=CCC(=C)[C@@H]1CC1=C2OC=C1C BZQURGSQMBBPRU-DZGCQCFKSA-N 0.000 claims description 4
- BZQURGSQMBBPRU-ZFWWWQNUSA-N Lindestrene Natural products C=C1[C@H]2[C@@](C)(C=CC1)Cc1occ(C)c1C2 BZQURGSQMBBPRU-ZFWWWQNUSA-N 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- 229940044952 vaginal foam Drugs 0.000 claims description 4
- 239000000259 vaginal foam Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 229940044959 vaginal cream Drugs 0.000 claims description 3
- 239000000522 vaginal cream Substances 0.000 claims description 3
- 229940044950 vaginal gel Drugs 0.000 claims description 3
- 239000000029 vaginal gel Substances 0.000 claims description 3
- 229940098946 vaginal ointment Drugs 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- AUSAHAHDEVYCOC-DZGCQCFKSA-N (4as,8as)-3,5,8a-trimethyl-4a,9-dihydro-4h-benzo[f][1]benzofuran Chemical compound C([C@]1(C)C2)=CC=C(C)[C@@H]1CC1=C2OC=C1C AUSAHAHDEVYCOC-DZGCQCFKSA-N 0.000 claims 1
- AUSAHAHDEVYCOC-UHFFFAOYSA-N 106001-39-2 Natural products C1C2(C)C=CC=C(C)C2CC2=C1OC=C2C AUSAHAHDEVYCOC-UHFFFAOYSA-N 0.000 claims 1
- 240000005125 Myrtus communis Species 0.000 claims 1
- 235000013418 Myrtus communis Nutrition 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- -1 vaginal tampon Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 description 14
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 238000002657 hormone replacement therapy Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000000699 topical effect Effects 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000000307 commiphora myrrha gum Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000014594 pastries Nutrition 0.000 description 4
- 240000003890 Commiphora wightii Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 238000005461 lubrication Methods 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000001256 steam distillation Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 230000001457 vasomotor Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000159174 Commiphora Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010016825 Flushing Diseases 0.000 description 2
- 229930008672 Furanosesquiterpene Natural products 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000007691 collagen metabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 description 2
- 239000002511 suppository base Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000159188 Commiphora habessinica Species 0.000 description 1
- 241001033433 Commiphora schimperi Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010014522 Embolism venous Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229920002675 Polyoxyl Polymers 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010065813 Vaginal fistula Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002192 cholecystectomy Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000002573 colposcopy Methods 0.000 description 1
- 239000001555 commiphora myrrha gum extract Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 201000004228 ovarian endometrial cancer Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 239000008299 semisolid dosage form Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000004043 venous thromboembolism Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Description
ミルラは、Commiphora molmol EnglerおよびCommiphora mukul以外のCommiphora近縁種の幹および枝から得られるオレオガム(oleo−gum)樹脂である。Commiphora mukul(属名は共通するが)は、ミルラを得るために用いることはできない。Commiphora molmol Englerは時には、Commiphora myrrhaまたはCommiphora myrrha(Nees)Englerとも呼ばれる。ミルラを得るための適切なCommiphora molmol近縁種は、Commiphora abyssinica EnglerおよびCommiphora schimperi Englerである。薬局方のミルラは一般に、Commiphora molmol Englerから得られるが、他の近縁種(具体的には、上記で言及されるもの)もまた十分適している。
閉経期とは、卵巣の濾胞活性の消失に起因する周期的な月経の永久的な停止と定義される。エストロゲン濃度の低下は、急性効果および長期効果の両方に関係する。確立された急性の症状は、血管運動不安定(顕性症状としては顔面潮紅および寝汗)ならびに膣の委縮(顕性症状としては膣乾燥、かゆみ、火照り(灼熱感)および不快感)である。
−有糸分裂活性の低下、それによって膣の裏層は、より薄くかつより脆弱になる;
−結合組織におけるコラーゲン含量の低下;
−血流の低下および膣の潤滑の低下;
これによって、膣の症状、ならびに、膣粘膜の蒼白(pallor)、乾燥およびしわの減少という所見がもたらされる。
− 脂肪、油性または油型の基剤を、この基剤材料の融解温度を超える高温で融解して融解物を得る工程と、
− 唯一の薬学的に活性な成分としてのミルラからなる、膣剤形の更年期症状としての膣萎縮処置剤を、この基剤の材料およびミルラの合計に対して0.1〜10パーセントの量でこの融解物に添加し、それによってこの基剤とミルラとの混合物を得る工程と、
− この混合物を撹拌する工程と、
− この混合物を少なくとも1つの鋳型中に注ぐ工程と、
− この混合物を室温まで冷却する工程と、
− この固化した混合物を鋳型から取り出す工程と、
を有する、更年期症状としての膣の萎縮に対する、それぞれ薬学的調製物または医薬品を調製するための方法によって解決される。
Claims (14)
- ミルラからなる、膣剤形の更年期症状としての膣萎縮処置剤。
- 前記ミルラが、粉末樹脂、ミルラのチンキ剤またはミルラの抽出物の形態で存在するという点で特徴付けられる、請求項1に記載の膣萎縮処置剤。
- ミルラの前記抽出物が、水性抽出物、乾燥抽出物、または親油性抽出物であるという点で特徴付けられる、請求項2に記載の膣萎縮処置剤。
- 前記ミルラのチンキ剤またはミルラの抽出物がフラノオイデスマ−1,3−ジエン、リンデストレンおよびクルゼレンを主要成分として含むという点で特徴づけられる、請求項2または3に記載の膣萎縮処置剤。
- 前記ミルラが半固体の膣剤形で、具体的には、軟膏、クリームまたはゲルとして存在するという点で特徴づけられる、請求項1〜4のいずれかに記載の膣萎縮処置剤。
- 前記ミルラが液体の膣剤形で、具体的には、液体、エマルジョン、または懸濁液として存在するという点で特徴づけられる、請求項1〜4のいずれかに記載の膣萎縮処置剤。
- 前記ミルラが、膣用フォームまたは膣用タンポンとして存在するという点で特徴づけられる、請求項1〜4のいずれかに記載の膣萎縮処置剤。
- 前記ミルラが、固体の膣剤形で、具体的には、錠剤、カプセルまたは坐剤として存在するという点で特徴づけられる、請求項1〜4のいずれかに記載の膣萎縮処置剤。
- 前記ミルラが、毎日、具体的には、1日に1回用いられるという点で特徴づけられる、請求項1〜8のいずれかに記載の膣萎縮処置剤。
- 更年期症状としての膣の萎縮の処置のための膣剤形の薬学的調製物であって、具体的には、唯一の薬学的な活性成分としてのミルラからなる、膣剤形の更年期症状としての膣萎縮処置剤を含んでいる、膣用軟膏、膣用クリーム、膣用ゲル、膣用液体、膣用エマルジョン、膣用懸濁液、膣用フォーム、膣用タンポン、膣用錠剤、膣用カプセル、または膣用坐剤。
- 請求項10に記載の薬学的調製物であって、膣用錠剤、膣用カプセルまたは膣用坐剤の形態で存在し、かつ本質的に脂肪、油性または油型の基剤、例としては、ココアバター、固い脂肪、または半合成のトリグリセリドおよびミルラからなるという点で特徴付けられる、薬学的調製物。
- 請求項11に記載の薬学的調製物であって、前記錠剤,カプセルまたは坐剤が0.5〜5グラムの重量を有し、ここで前記ミルラの含量が該錠剤、カプセルまたは坐剤の総重量の0.1〜10重量パーセントであるという点で特徴付けられる、薬学的調製物。
- 更年期症状としての膣の萎縮に対する薬学的調製物を調製するための方法であって、以下の工程:
脂肪、油性または油型の基剤を高温で融解して融解物を得る工程と、
唯一の薬学的成分としてのミルラからなる、膣剤形の更年期症状としての膣萎縮処置剤を、該脂肪、油性または油型の基剤およびミルラの合計に対して0.1〜10重量パーセントの量で該融解物に対して添加して混合物を得る工程と、
該混合物を撹拌する工程と、
該混合物を少なくとも1つの鋳型中に注ぐ工程と、
該混合物を室温まで冷却する工程と、
該固化した混合物を該鋳型から取り出す工程と、
によって特徴付けられる、方法。 - 請求項13に記載の方法であって、前記鋳型が、少なくとも1つの膣用錠剤、膣用カプセルまたは膣用坐剤が得られるように前記混合物を形成するという点で特徴づけられる、方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11158593.1A EP2500026B1 (en) | 2011-03-17 | 2011-03-17 | Treatment of menopausal symptoms as novel indication for myrrh |
US13/050,225 | 2011-03-17 | ||
US13/050,225 US8287924B2 (en) | 2011-03-17 | 2011-03-17 | Treatment of menopausal symptoms as novel indication for myrrh |
EP11158593.1 | 2011-03-17 | ||
PCT/EP2012/054548 WO2012123539A1 (en) | 2011-03-17 | 2012-03-15 | Treatment of vaginal atrophy as novel indication for myrrh |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014508158A JP2014508158A (ja) | 2014-04-03 |
JP5519879B2 true JP5519879B2 (ja) | 2014-06-11 |
Family
ID=45929506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013555906A Expired - Fee Related JP5519879B2 (ja) | 2011-03-17 | 2012-03-15 | ミルラの新規な適用としての更年期症状としての膣の委縮の処置 |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP5519879B2 (ja) |
KR (1) | KR20130130034A (ja) |
AU (1) | AU2012228213B2 (ja) |
BR (1) | BR112013023092A2 (ja) |
CA (1) | CA2829792C (ja) |
CO (1) | CO6771460A2 (ja) |
MX (1) | MX352788B (ja) |
WO (1) | WO2012123539A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2967506A1 (en) | 2016-01-18 | 2017-07-18 | Nadiah Abdulkarim A. Alessa | Composition for treatment and preventative of the human papilloma virus hpv infection, ulcerations and boils |
WO2020006191A1 (en) * | 2018-06-29 | 2020-01-02 | The Procter & Gamble Company | Vaginal care compositions |
DE112020006124T5 (de) * | 2019-12-15 | 2022-12-08 | Banooye Armaghan Teb | Pflanzliche Zusammensetzungen und Verabreichungsverfahren zur Behandlung von Infektionen und Entzündungen der vulvovaginalen und der Beckenorgane |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592912A (en) | 1983-10-31 | 1986-06-03 | Harriet Nickolaus | Ache and pain relieving and preventing composition |
US4719111A (en) | 1985-06-14 | 1988-01-12 | Wilson Lynn M | Novel composition for treatment of decubitus ulcers |
JPS63104924A (ja) * | 1986-10-20 | 1988-05-10 | Kanebo Ltd | 膣坐剤 |
AU630561B2 (en) | 1990-06-12 | 1992-10-29 | Cathy Palou | A therapeutic preparation containing myrrh for treating skin disorders |
US6350784B1 (en) * | 1996-02-12 | 2002-02-26 | Meryl J. Squires | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
US5248503A (en) | 1992-01-03 | 1993-09-28 | Emanuel King Rosalba | Herbal dietary supplement |
US6077513A (en) | 1996-05-02 | 2000-06-20 | Massoud; Ahmed Mohamed Ali | Drug for treatment of bilharziasis (Schistosomiasis) |
ZA200000192B (en) * | 1998-10-30 | 2000-08-07 | Jullienne Jacques Roger Jean M | Novel composition. |
US6893648B2 (en) | 2002-01-04 | 2005-05-17 | Harold Mermelstein | Composition and method for treatment of vaginal dryness |
CN1559586A (zh) * | 2004-03-04 | 2005-01-05 | 健 曹 | 一种治疗妇科疾病的外用中成药 |
CN1679687A (zh) | 2005-02-02 | 2005-10-12 | 姚素英 | 一种治疗妇科疾病外用胶囊及制备方法 |
CN101057892B (zh) * | 2006-04-19 | 2010-11-10 | 河南省宛西制药股份有限公司 | 一种治疗阴道疾病的药物组合物及其制备方法和应用 |
CN101849981B (zh) * | 2010-06-22 | 2011-11-23 | 南京中医药大学 | 一种具有抗妇科肿瘤作用的没药有效部位及其制备方法和其应用 |
-
2012
- 2012-03-15 KR KR1020137021591A patent/KR20130130034A/ko not_active Application Discontinuation
- 2012-03-15 CA CA2829792A patent/CA2829792C/en active Active
- 2012-03-15 MX MX2013010415A patent/MX352788B/es active IP Right Grant
- 2012-03-15 AU AU2012228213A patent/AU2012228213B2/en not_active Ceased
- 2012-03-15 WO PCT/EP2012/054548 patent/WO2012123539A1/en active Application Filing
- 2012-03-15 JP JP2013555906A patent/JP5519879B2/ja not_active Expired - Fee Related
- 2012-03-15 BR BR112013023092A patent/BR112013023092A2/pt not_active Application Discontinuation
-
2013
- 2013-09-30 CO CO13231573A patent/CO6771460A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2013010415A (es) | 2013-12-02 |
JP2014508158A (ja) | 2014-04-03 |
WO2012123539A1 (en) | 2012-09-20 |
AU2012228213B2 (en) | 2015-08-06 |
KR20130130034A (ko) | 2013-11-29 |
BR112013023092A2 (pt) | 2016-12-06 |
AU2012228213A1 (en) | 2013-09-12 |
MX352788B (es) | 2017-12-05 |
CO6771460A2 (es) | 2013-10-15 |
CA2829792A1 (en) | 2012-09-20 |
CA2829792C (en) | 2017-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Uysal et al. | Investigating the effect of rose essential oil in patients with primary dysmenorrhea | |
JPH0369886B2 (ja) | ||
JP2022079461A (ja) | 女性更年期症状改善用組成物 | |
JP2006241044A (ja) | エストロゲン様作用剤 | |
US11903977B2 (en) | Topical composition comprised of cod li [[ ]]ver oil for treating wounds and skin disorders | |
JP5519879B2 (ja) | ミルラの新規な適用としての更年期症状としての膣の委縮の処置 | |
US8287924B2 (en) | Treatment of menopausal symptoms as novel indication for myrrh | |
RU2429867C1 (ru) | Суппозитории с экстрактом личинок большой восковой моли и экстрактом прополиса для лечения гинекологических заболеваний | |
US20170333446A1 (en) | Compounded formula for menopause relief | |
JP4837930B2 (ja) | 抗エストロゲン作用剤 | |
EP2500026B1 (en) | Treatment of menopausal symptoms as novel indication for myrrh | |
CN100370973C (zh) | 一种治疗胸痹的中药制剂 | |
Orbe et al. | Medicinal herbs: Its therapeutic use in obstetrics and gynaecology | |
Alamoudi et al. | Vitex agnus castus and some female disorders: A review | |
KR20110000250A (ko) | 전립선을 위한 건강식품 및 이의 제조방법 | |
Milica et al. | Aromatherapy: Therapy with fragrances of lavender essential oil | |
do Sameiro Barroso | Medicine and magic in a recipe of Aspasia, a sixth-century CE Byzantine physician | |
WO2022075376A1 (ja) | トランスサイレチン四量体安定化剤、及び、トランスサイレチンアミロイドーシス予防剤又は進行抑制剤 | |
Painter et al. | Transdermal Delivery | |
JP2006131572A (ja) | 月経関連症状の緩和剤 | |
Ray | Use of dietary supplements to alleviate vasomotor symptoms among menopausal women | |
TW201534320A (zh) | 曼加薑黃萃取物作爲克服前列腺問題的治療 | |
van Die | Herbal medicine and menopause: an historical perspective | |
CN113876762A (zh) | 丹酚酸y在治疗毛囊皮脂腺炎中的应用 | |
JP2006131571A (ja) | 月経関連症状の緩和剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20140124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140327 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140403 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5519879 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |